Page 7
#biopharma #pharma
BioPharma Dive Weekender | 6 April 2019
Headlines >>>
What to look for after Zolgensma’s launch
Allergan eye drug fails to impress on safety, upping pressure ahead of key meeting
Amgen, Novartis clash in dispute over Aimovig partnership
AveXis buys its 4th US plant in preparation of Zolgensma launch
Early pancreatic cancer data give Clovis a new path in PARP market
Roche must ask Spark shareholders once again to sell
SPONSORED CONTENT BY BIOPHARMA DIVE BRAND STUDIO
How population-based RWD enhances safety signal reliability
Safety scientists, epidemiologists and researchers are integrating population-based RWD into all phases of safety assessments to enhance the reliability of their data and bridge the gap between safety signal detection and risk management.
UPCOMING EVENTS
| How Population-Based RWD Drives Data Accuracy and Reduces Risk April 9, 2019 – April 9, 2019 | Webinar 2 pm ET |
| The New Model for eCOA: Modernizing Technology, Process and Science to Change the Game April 10, 2019 – April 10, 2019 | Webinar 2 PM ET |
| FDA guidance to using eConsent in clinical trials May 2, 2019 – May 2, 2019 | Webinar 2 pm ET |
Read all the above…
… and more by signing up via this link for Biopharma Dive >>>
About BioPharma Dive
Our mission is to provide busy execs like you with an overview of the BioPharma industry in 60 seconds. BioPharma Dive is a product of Industry Dive.
View other Industry Dive publications.
Healthcare Dive weekender | 6 April 2019
Headlines >>>
CVS-Aetna judge to hear testimony from critics next month
The American Medical Association is expected to be among the witnesses called by the unconventional federal judge.
Academic medical centers face headwinds in shift to value-based care, Moody’s says
CMS finalizes nontraditional MA benefits, use of encounter data
Growth in telehealth use outpaces urgent care centers, retail clinics
Cigna, Express Scripts promise to cap out-of-pocket insulin costs
Amazon’s Alexa now has HIPAA-compliant features
Six companies taking part in the online giant’s invitation-only developer program launched their features Thursday, including Atrium Health, Cigna, Express Scripts and Livongo.
Recommended
DEEP DIVE
Hospitals look to venture capital as R&D extension
UPMC Enterprises President Tal Heppenstall told Healthcare Dive the University of Pittsburgh Medical Center venture arm plans on spinning out two companies by the middle of this year.
Upcoming EVENT
| The World Conference on Quality and Improvement May 20, 2019 – May 22, 2019 | Fort Worth, TX |
Read all the above and more via the link below
About BioPharma Dive
Our mission is to provide busy execs like you with an overview of the industry in 60 seconds. BioPharma Dive is a product of Industry Dive.
Healthcare Dive weekender | 30 March 2019
SPONSORED CONTENT BY IBM
How analytics and AI can impact an entire healthcare organization
From billing and medical staff to the entire supply chain, analytics and AI can impact an entire healthcare organization. Find out why healthcare leaders are turning to these tools to help manage risk and boost profits.
Read all the above and more by signing up via this link for Healthcare Dive >>>
About Healthcare Dive
Our mission is to provide busy execs like you with an overview of the industry in 60 seconds. Healthcare Dive is a product of Industry Dive.
View other Industry Dive publications.
Healthcare Dive is a product of Industry Dive, Inc.. 1575 Eye St NW, 4th Floor, Washington, DC 20005. We value your privacy. We won’t share your email address with anyone else without your permission
MedTech Dive’s Top News | Weekender | 6 April 2019
Headlines >>>
FEATURED: Canada, France take hard action on textured breast implants
The week after an FDA advisory panel spotlighted breast implant-associated cancer, French regulators are banning all macrotextured breast implants, while Health Canada will likely halt sales of Allergan’s Biocell model.
Other headlines:
Bigfoot CEO talks data-driven diabetes care and becoming a service company
FDA unveils framework for AI-based medical devices
J&J closes Auris Health buy, Advanced Sterilization Products divestiture
Q1’19 digital health investments slow, but IPOs brewing
FDA gives PMA to injection treatment for knee pain
Read all the above and more by signing up via this link for MedTech Dive >>>
About MedTech Dive
Our mission is to provide busy execs like you with an overview of the industry in 60 seconds. MedTech Dive is a product of Industry Dive.
View other Industry Dive publications
Page 7
